LJankowiak
TL3 Regular · Madrid, ES
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 23 November 2024 · last posted 2h · groups: analytical-chemists
141 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #137 · Meta › Feature requests · 28 Jul 2026 · 3 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Pooling trials with different estimands Replied, post #131 · Evidence › Meta-analyses · 26 Jul 2026 · 0 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #15 · Clinical › Bloodwork · 19 Jul 2026 · 31 likes This follows post #13 rather than contradicting it. Taking egfr fluctuation seriously for a moment rather than deflecting: the honest position is that the community has…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #27 · Access › Shortages · 17 Jul 2026 · 10 likes Taking post #25 at face value and following it one step further. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #45 · Compounds › Secretagogues & GH axis · 16 Jul 2026 · 1 like Narrowing post #42, because the general version has more than one answer. Where the GHRH analogues versus ghrelin mimetics reasoning breaks down for me is the step from…
-
Here for the analytics and not much else Replied, post #34 · Lounge › Introductions · 14 Jul 2026 · 4 likes Glad to see another member from outside the usual regions. The access and regional categories are thin for anywhere that is not the UK, EU or North America, and a dated…
-
Request: a per-category review queue Replied, post #102 · Meta › Feature requests · 14 Jul 2026 · 0 likes Post #99 and I disagree about the size of the effect, not about the direction. Request with the use case rather than the feature. I frequently want every topic that…
-
Immortal time bias in a claims-database study — one year on Replied, post #18 · Evidence › Study critique · 11 Jul 2026 · 7 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
-
How much context is too much context in a first post? Replied, post #45 · Start Here › How to Ask · 8 Jul 2026 · 0 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #60 · Evidence › Journal club · 7 Jul 2026 · 10 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #97 · Sourcing › Vendor reports · 7 Jul 2026 · 21 likes I had written a reply contradicting post #93 and deleted it. Here is what survived. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if…
-
Sleep quality changes during weight loss Replied, post #11 · Wellbeing › Sleep · 6 Jul 2026 · 0 likes Post #7 and I disagree about the size of the effect, not about the direction. A referral for a proper sleep study answers in one night what months of forum discussion…
-
What a good consultation looks like from the other side Replied, post #56 · Clinical › Prescriber conversations · 5 Jul 2026 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. One of those cases where…
-
Insurance and replacement policies, compared Replied, post #64 · Sourcing › Logistics · 5 Jul 2026 · 3 likes Insurance and replacement policies is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Request: a per-category review queue Replied, post #69 · Meta › Feature requests · 30 Jun 2026 · 0 likes Request from the analytics side: allow a table in a post to be marked as data rather than layout, so it can be copied without the formatting. Half the tables here are…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #3 · Compounds › Repair & healing peptides · 27 Jun 2026 · 0 likes Research use only, not approved for human use, and in this family that statement carries more weight than usual because the published human safety data is effectively…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #27 · Pharmacology › Receptor biology · 25 Jun 2026 · 4 likes Amylin signalling reaches satiety through a distinct receptor complex, which is the mechanistic basis for expecting an amylin analogue and an incretin agonist to add…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #62 · Start Here › How to Ask · 22 Jun 2026 · 24 likes No disagreement from me. Posting only so the question does not look ignored.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #44 · Analytics › HPLC & UHPLC · 18 Jun 2026 · 1 like Building on post #42 rather than restating it. A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #24 · Sourcing › Independent verification · 13 Jun 2026 · 5 likes Whatever the answer on Chain of custody turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
A site rotation scheme that is easy enough to actually follow Replied, post #86 · Practice › Administration · 12 Jun 2026 · 12 likes Post #84 and I disagree about the size of the effect, not about the direction. Note the site alongside the dose. If a local reaction appears three weeks later you will…
-
Follow-up: Sleep quality changes during weight loss Replied, post #38 · Wellbeing › Sleep · 5 Jun 2026 · 20 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #27 · Practice › Storage & stability · 31 May 2026 · 32 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #67 · Practice › Administration · 24 May 2026 · 16 likes Everything in post #63 holds. The case it does not cover is the one I have. If you have to inject at a different time of day than usual, that is a much smaller…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #25 · Wellbeing › Sleep · 23 May 2026 · 24 likes Where I would push back on the Insomnia consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #54 · Practice › Reconstitution · 15 May 2026 · 4 likes Post #53 is right about the mechanism and I think understates the practical bit. Filter needles are worth considering if you are drawing from a glass ampoule and are…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #123 · Compounds › Tirzepatide · 14 May 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #36 · Safety › Contraindications · 12 May 2026 · 5 likes Following this. I have the same question and no better information than the first post.
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #7 · Analytics › HPLC & UHPLC · 2 May 2026 · 26 likes Taking post #4 at face value and following it one step further. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #54 · Clinical › Bloodwork · 1 May 2026 · 12 likes On post #52 — agreed on the reasoning, with one qualification. On Thyroid function tests during substantial, I would rather understate and be corrected upward than…
-
When a dose reduction is the correct response to a side effect Replied, post #16 · Practice › Dosing & titration · 28 Apr 2026 · 31 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Journal club: is percentage weight change the right endpoint? Replied, post #108 · Evidence › Journal club · 27 Apr 2026 · 28 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Five questions in one post gets you one answer — how to split them Replied, post #61 · Start Here › How to Ask · 21 Apr 2026 · 0 likes Post #60 answers the question as asked. The question underneath it is different. The question underneath five questions is usually "how would I tell?" rather than "what…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #90 · Compounds › Tirzepatide · 20 Apr 2026 · 29 likes Narrowing post #87, because the general version has more than one answer. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #88 · Analytics › Mass spectrometry · 17 Apr 2026 · 18 likes If someone has run Charge states properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Validating a calculator against hand arithmetic Replied, post #17 · Data & Tools › Calculators · 11 Apr 2026 · 1 like This follows post #14 rather than contradicting it. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat:…
-
The anatomy of a question that gets answered within an hour Replied, post #11 · Start Here › How to Ask · 4 Apr 2026 · 0 likes Building on post #9 rather than restating it. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this…
-
Cold solution and stinging: the simplest fix Replied, post #12 · Practice › Administration · 31 Mar 2026 · 31 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. The…
-
Getting a referral rather than a refusal Replied, post #9 · Clinical › Prescriber conversations · 23 Mar 2026 · 11 likes Coming back to post #7, because the follow-up matters more than the original answer. Practical note on getting a referral: write down what you expect before you look.…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #25 · Start Here › Welcome · 15 Mar 2026 · 11 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
-
Transporting a vial for a weekend away — a second dataset Replied, post #7 · Practice › Storage & stability · 14 Mar 2026 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #75 · Compounds › Semaglutide · 7 Mar 2026 · 2 likes Building on post #73 rather than restating it. Worth separating two things this subcategory keeps merging: what the molecule does, which is reasonably well…
-
Second pass at: What to keep a record of at the point of payment Replied, post #14 · Sourcing › Payments · 27 Feb 2026 · 2 likes Nothing here is financial advice and none of this is a route to a transaction. It is a description of what members record. That is the shape of it. The detail is where…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #52 · Analytics › Impurities & related substances · 26 Feb 2026 · 1 like Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
Measurement error in a self-reported exposure Started this topic · Evidence › Study critique · 21 Feb 2026 · 14 likes Posting this under the heading it deserves: Measurement error in a self-reported exposure Everything below is what sits behind that. The question about measurement…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #72 · Practice › Dosing & titration · 18 Feb 2026 · 2 likes Where I part company with post #70, and it is a narrow parting. A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #85 · Pharmacology › Pharmacokinetics · 17 Feb 2026 · 25 likes The failure mode on Half-life is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #45 · Clinical › Special populations · 17 Feb 2026 · 0 likes Post #44 is the version of this I will quote in future. One addition. The most useful contribution here is usually a citation to whichever published document comes…
-
Second pass at: Identical chromatograms across two different lots Replied, post #7 · Sourcing › Red flags · 14 Feb 2026 · 7 likes Taking post #4 at face value and following it one step further. A document with no method identification is not evidence of anything wrong. It is evidence that the…
-
Trifluoroacetate content and its consequences Replied, post #133 · Analytics › Impurities & related substances · 11 Feb 2026 · 0 likes On post #129 — agreed on the reasoning, with one qualification. Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they elute…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #94 · Clinical › Special populations · 6 Feb 2026 · 11 likes Understood. Thank you for being specific about the limits of it.
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #35 · Compounds › Retatrutide · 29 Jan 2026 · 2 likes Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some pharmacokinetics. That is a genuinely early…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #95 · Clinical › Special populations · 26 Jan 2026 · 0 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question. It is…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #76 · Clinical › Special populations · 25 Jan 2026 · 0 likes I had written a reply contradicting post #74 and deleted it. Here is what survived. Body weight at the extremes of the studied range affects exposure and the trials…
-
Heterogeneity as information rather than as a nuisance Replied, post #64 · Evidence › Meta-analyses · 16 Jan 2026 · 27 likes An honest declaration on heterogeneity: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #8 · Practice › Administration · 12 Jan 2026 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #52 · Pharmacology › Receptor biology · 11 Jan 2026 · 0 likes Signalling through cyclic AMP is the canonical pathway and is not the only one. Beta-arrestin recruitment differs between ligands and its clinical significance here is…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #9 · Pharmacology › Pharmacokinetics · 5 Jan 2026 · 14 likes What I would check first on Washout is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Coverage in the US: a map of the usual obstacles Replied, post #27 · Regional › North America · 25 Dec 2025 · 22 likes The honest answer on coverage is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most people…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #48 · Analytics › Method validation · 18 Dec 2025 · 6 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
Tracking a preprint to publication: a worked example Replied, post #98 · Evidence › Preprints · 10 Dec 2025 · 0 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors. I…
-
DXA precision and the least significant change for lean mass Replied, post #48 · Outcomes › Body composition · 7 Dec 2025 · 18 likes Circumference measurements at marked sites, taken consistently, track composition change better than most people expect for the cost. Someone will know this better than…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Started this topic · Pharmacology › Receptor biology · 2 Dec 2025 · 2 likes Posting this under the heading it deserves: Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long version Everything below is what sits…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #59 · Practice › Interactions · 29 Nov 2025 · 0 likes I read post #57 twice before replying, because I had assumed the opposite. Practical note on Warfarin and altered intake: write down what you expect before you look.…
-
Sleep quality changes during weight loss — what changed since Replied, post #75 · Wellbeing › Sleep · 23 Nov 2025 · 21 likes Post #72 is the version of this I will quote in future. One addition. Eating patterns shift substantially and late intake affects sleep independently of anything…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #16 · Compounds › Other compounds · 22 Nov 2025 · 1 like Sequence verification: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #13 · Clinical › Bloodwork · 19 Nov 2025 · 8 likes An update on my earlier reference intervals post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #4 · Safety › Contraindications · 13 Nov 2025 · 0 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. Severe gastrointestinal disease interacts with a delayed-emptying…
-
Absolute versus relative contraindications Replied, post #4 · Safety › Contraindications · 9 Nov 2025 · 0 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #20 · Practice › Storage & stability · 7 Nov 2025 · 21 likes Where I part company with post #18, and it is a narrow parting. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
-
Follow-up: Why appetite effects are mostly central Replied, post #88 · Pharmacology › Receptor biology · 6 Nov 2025 · 0 likes Two sentences on appetite effects and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #10 · Practice › Dosing & titration · 2 Nov 2025 · 27 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #24 · Start Here › How to Ask · 25 Oct 2025 · 1 like Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition. It cost nothing to check…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #15 · Start Here › How to Ask · 21 Oct 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #13 · Safety › Adverse events · 11 Oct 2025 · 28 likes Reporting here and reporting to a national scheme are not alternatives. The second is what feeds safety surveillance.
-
The headache that turns out to be dehydration Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 10 Oct 2025 · 19 likes Headache has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Lipase elevation without symptoms: the interpretation problem Replied, post #10 · Clinical › Bloodwork · 7 Oct 2025 · 23 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. I have…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #8 · Compounds › Retatrutide · 7 Oct 2025 · 18 likes Post #4 put the caveat in the right place and I want to underline it. No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #94 · Practice › Administration · 5 Oct 2025 · 20 likes Coming back to post #92, because the follow-up matters more than the original answer. Needle length matters less than angle for subcutaneous delivery in most people. A…
-
Oral semaglutide bioavailability and its variability between people Replied, post #7 · Compounds › Oral incretins · 1 Oct 2025 · 18 likes This follows post #4 rather than contradicting it. Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #131 · Wellbeing › Mental health · 12 Sep 2025 · 23 likes This follows post #128 rather than contradicting it. Answering the history of disordered eating question as asked, then the question I think is meant. As asked: yes,…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #137 · Practice › Storage & stability · 11 Sep 2025 · 2 likes I read post #133 twice before replying, because I had assumed the opposite. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
About the Prescriber conversations category Replied, post #5 · Clinical › Prescriber conversations · 7 Sep 2025 · 13 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #71 · Clinical › Special populations · 31 Aug 2025 · 0 likes Everything in post #67 holds. The case it does not cover is the one I have. History of disordered eating is one of those subjects where the general answer and the…
-
Research-use-only labelling: what it means and what it does not Replied, post #26 · Sourcing › Regulatory · 26 Aug 2025 · 4 likes Worth separating two things that post #24 runs together. Reframing research-use-only labelling slightly, because I think the disagreement is about the question rather…
-
When a preprint is the best available evidence and we say so Replied, post #60 · Evidence › Preprints · 15 Aug 2025 · 1 like The arithmetic in post #57 is right; the assumption feeding it is the part to check. A preprint that has been up for two years without appearing in a journal is telling…
-
A request that was declined, and the reasoning — a second dataset Replied, post #62 · Documentation › Wiki requests · 12 Aug 2025 · 23 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #24 · Compounds › Oral incretins · 8 Aug 2025 · 6 likes A small molecule can be characterised by nuclear magnetic resonance and by mass spectrometry against a reference standard, which is a considerably stronger identity…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #7 · Practice › Administration · 2 Aug 2025 · 5 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #6 · Data & Tools › Datasets · 31 Jul 2025 · 16 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #12 · Analytics › Method validation · 4 Jul 2025 · 19 likes Answering the question post #8 raises rather than the one it answers. An independent laboratory's method being different from the supplier's is not a discrepancy. It…
-
Persistent vomiting and the threshold for seeking help Started this topic · Safety › Adverse events · 27 Jun 2025 · 0 likes On the subject in the title: Persistent vomiting and the threshold for seeking help Working notes rather than a conclusion. Trying to work out what would count as…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #141 · Compounds › Cagrilintide & amylin analogues · 26 Jun 2025 · 15 likes Confirming post #138 from a second method, which matters more than confirming it from a second person. Speaking only to amylin analogue mechanism as I have actually…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #90 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 3 likes Second-hand on CagriSema phase 2 paper, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #57 · Access › Insurance & coverage · 10 Jun 2025 · 5 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #21 · Pharmacology › Pharmacokinetics · 30 May 2025 · 0 likes What would change my mind on Clearance pathways is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #35 · Nutrition & Training › Protein & intake · 25 May 2025 · 3 likes Post #33 and I disagree about the size of the effect, not about the direction. The arithmetic on Shakes versus food is the easy part and it is where the errors are,…
-
Counter-ion content and its effect on measured mass Replied, post #43 · Analytics › Mass spectrometry · 20 May 2025 · 0 likes Following this. I have the same question and no better information than the first post.
-
A report I filed that turned out to be wrong, and the correction Replied, post #59 · Sourcing › Vendor reports · 18 May 2025 · 0 likes Adding the measurement that post #58 says would settle it. The format we ask for is compound, lot, testing service, method as reported, result, and the certificate…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #3 · Evidence › Journal club · 12 May 2025 · 11 likes Helpful, and short, which on this subject is harder than long.
-
A claim built entirely on a subgroup analysis Replied, post #29 · Evidence › Study critique · 11 May 2025 · 0 likes Placebo-controlled versus active-controlled changes what a result means entirely, and comparing across the two is one of the most common errors in this subcategory.…
-
Water content on a certificate and why it changes the arithmetic Replied, post #18 · Analytics › COA interpretation · 11 May 2025 · 7 likes Post #14 describes the usual case. This is about the unusual one. What fields matter on a certificate: lot number matching the vial, test date, the analytical method…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #106 · Evidence › Journal club · 22 Apr 2025 · 0 likes The version of STEP 1 that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #7 · Clinical › Bloodwork · 15 Apr 2025 · 0 likes Post #5 answers the question as asked. The question underneath it is different. What I would tell a new member reading about Building a sensible monitoring schedule for…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #24 · Evidence › Journal club · 15 Apr 2025 · 19 likes A conflict-of-interest statement is worth reading aloud and is worth very little as a predictor. Design quality is what to spend the session on.
-
Talking to a therapist about this specifically — does this still hold? Replied, post #43 · Wellbeing › Mental health · 11 Apr 2025 · 6 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase. This is where my knowledge stops and I…
-
Scheduled maintenance and what will be unavailable Replied, post #101 · Meta › Announcements · 7 Apr 2025 · 0 likes Building on post #100 rather than restating it. I have three months of notes on scheduled maintenance and the honest summary is that the trend is real and the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #93 · Compounds › Cagrilintide & amylin analogues · 6 Apr 2025 · 0 likes Post #92 answers the question as asked. The question underneath it is different. On storage: aggregation-prone peptides are the ones where repeated warming and cooling…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #74 · Devices › Cold chain · 26 Mar 2025 · 0 likes Answering the question post #71 raises rather than the one it answers. Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #56 · Sourcing › Vendor reports · 16 Mar 2025 · 11 likes Date the submission as well as the result. Turnaround is part of what people want to know and it disappears if only one date is recorded. The short version is the first…
-
Retatrutide dose escalation in the published trials Replied, post #15 · Compounds › Retatrutide · 15 Mar 2025 · 1 like Right — I had this wrong and I am glad to have read it before it mattered.
-
Ipamorelin selectivity claims and where they came from Replied, post #19 · Compounds › Secretagogues & GH axis · 10 Mar 2025 · 8 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #49 · Practice › Reconstitution · 8 Mar 2025 · 19 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
When "no data" is the complete and final answer Replied, post #107 · Compounds › Other compounds · 2 Mar 2025 · 3 likes Everything in post #103 holds. The case it does not cover is the one I have. A compound with no established assay is a compound where a certificate can say almost…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #71 · Analytics › Mass spectrometry · 27 Feb 2025 · 33 likes The most useful reply I ever got about mass spectrometry was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Distinguishing a deletion sequence by mass alone Replied, post #117 · Analytics › Mass spectrometry · 21 Feb 2025 · 8 likes Something worth flagging about distinguishing a deletion sequence: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual Replied, post #2 · marked as the solution · Compounds › Tirzepatide · 19 Feb 2025 · 20 likes SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on stopping. It says nothing about a lower maintenance dose, because…
-
Reading an MS report that only gives you a single number Replied, post #7 · Analytics › Mass spectrometry · 8 Feb 2025 · 17 likes Building on post #6 rather than restating it. Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #21 · Analytics › COA interpretation · 18 Jan 2025 · 12 likes Post #19 and I disagree about the size of the effect, not about the direction. An itemised related-substances table with retention times says considerably more about…
-
A promotion I argued against, and why I lost Replied, post #65 · Documentation › Doc review · 18 Jan 2025 · 0 likes Counterpoint on promotion, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
-
Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 12 Jan 2025 · 15 likes Noted, and I have changed what I was going to do on the strength of it.
-
Oxidation pathways for methionine and tryptophan Replied, post #48 · Analytics › Impurities & related substances · 30 Dec 2024 · 4 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Reading a supplementary appendix and finding the interesting part Replied, post #51 · Evidence › Trials · 24 Dec 2024 · 0 likes Answering the reading a supplementary appendix question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #21 · Compounds › Semaglutide · 20 Dec 2024 · 3 likes The version of Semaglutide formulation that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
When to suspect the method rather than the sample Replied, post #51 · Analytics › Method validation · 15 Dec 2024 · 0 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.…
-
Washout with a one-week half-life: the arithmetic Replied, post #45 · Research Methods › N-of-1 designs · 1 Dec 2024 · 0 likes On post #41 — agreed on the reasoning, with one qualification. An observation about washout that I cannot explain and am posting anyway, on the principle that…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #45 · Access › Insurance & coverage · 28 Nov 2024 · 0 likes I read post #43 twice before replying, because I had assumed the opposite. Keep every document with dates in one place. An appeal months later is assembled from…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #13 · Start Here › Welcome · 14 Nov 2024 · 3 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Time to steady state after a dose increase Replied, post #32 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Building on post #29 rather than restating it. Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration,…
-
When "no data" is the complete and final answer Replied, post #13 · Compounds › Other compounds · 1 Nov 2024 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #84 · Clinical › Prescriber conversations · 24 Oct 2024 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #67 · Compounds › Other compounds · 23 Oct 2024 · 0 likes PT-141 was developed from the same family with a different receptor profile, and it has a considerably better documented human evidence base than most compounds…
-
Requesting a page: what makes a good request — what changed since Replied, post #25 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes Picking up post #22: that is the part I would want checked first. The commonest reason a good request stalls is that nobody converted it into a draft. A rough draft…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #5 · Clinical › Comorbidities · 26 Sep 2024 · 30 likes Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist. I have written this out…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #46 · Practice › Administration · 22 Sep 2024 · 26 likes I have no financial interest in anything named in this thread and I want to say so before I comment on site rotation scheme, because it is the sort of subject where it…
-
Signs of dehydration worth acting on Replied, post #17 · Safety › Adverse events · 16 Sep 2024 · 0 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #11 · Practice › Administration · 5 Sep 2024 · 0 likes Adding the measurement that post #10 says would settle it. Site reactions that appear immediately and settle within a day are described commonly here. Ones that appear…
-
Guidelines revision: what changed and why Replied, post #21 · Meta › Announcements · 25 Jul 2024 · 27 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Circumference measurements as a poor man's composition estimate Replied, post #18 · Outcomes › Body composition · 25 Jul 2024 · 9 likes Post #17 is the version of this I will quote in future. One addition. Report the method with the number, always. A composition figure without the method is not…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #48 · Evidence › Journal club · 21 Jul 2024 · 29 likes On post #46 — agreed on the reasoning, with one qualification. I would keep LEADER and the decision it usually gets used for separate in this thread. They are related…
-
The mass-error checker and its intended scope Replied, post #75 · Data & Tools › Calculators · 25 Jun 2024 · 1 like This is the sort of exchange that makes the archive worth searching.